Keeping Track of CML
Staying on top of a chronic disease is key to staying well. Managing these diseases can be tricky. Chronic myeloid leukemia (CML) is a great example.
Preventing Blood Clots Better Than Not
Who wants to be given a shot every single day for a month after surgery just to prevent the chance of developing a blood clot? People who really don’t want to get blood clots—that’s who.
Cancer Risks of Cancer Treatment
You do what you can – what you’re told – to beat the cancer. Chemotherapy is recommended and it works. Years later, though, you’re diagnosed with a blood cancer that could be related to the chemotherapy. Is this really happening?
Cancer Rx Granted Accelerated FDA Approval Path
The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.
Living With Chronic Myeloid Leukemia
People diagnosed with chronic myeloid leukemia (CML) are living longer than ever before. A number of effective therapies are available for all phases of the disease, but living with CML has its challenges.
FDA Approves Pomalyst for Advanced Multiple Myeloma
The US Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Finding the Path of No Return for Kids with Cancer
The cure rate for one type of blood cancer that affects children - acute lymphoblastic leukemia (ALL) – is now about 80 percent. For the remaining 20 percent of kids who develop the disease, the outlook can be dire.
New Rx for Advanced Multiple Myeloma
Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone marrow grow out of control.
Paradigm Shift - Healthy vs. Cancerous Cells
If you focus on maintaining a healthy lifestyle, you’re less likely to get sick. That’s simple logic. Researchers now think this approach might be an effective way to treat cancer.
A Combination Leukemia Can’t Take
Many patients with chronic lymphocytic leukemia do pretty well with standard treatment. The disease retreats and stays in remission. However, some patients aren’t so fortunate. A new combination may be just what these patients need.